Correlation Between Algernon Pharmaceuticals and Seelos Therapeutics
Can any of the company-specific risk be diversified away by investing in both Algernon Pharmaceuticals and Seelos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algernon Pharmaceuticals and Seelos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Algernon Pharmaceuticals and Seelos Therapeutics, you can compare the effects of market volatilities on Algernon Pharmaceuticals and Seelos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algernon Pharmaceuticals with a short position of Seelos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algernon Pharmaceuticals and Seelos Therapeutics.
Diversification Opportunities for Algernon Pharmaceuticals and Seelos Therapeutics
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Algernon and Seelos is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Algernon Pharmaceuticals and Seelos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seelos Therapeutics and Algernon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algernon Pharmaceuticals are associated (or correlated) with Seelos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seelos Therapeutics has no effect on the direction of Algernon Pharmaceuticals i.e., Algernon Pharmaceuticals and Seelos Therapeutics go up and down completely randomly.
Pair Corralation between Algernon Pharmaceuticals and Seelos Therapeutics
If you would invest 4.63 in Algernon Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 1.54 from holding Algernon Pharmaceuticals or generate 33.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
Algernon Pharmaceuticals vs. Seelos Therapeutics
Performance |
| Timeline |
| Algernon Pharmaceuticals |
| Seelos Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Algernon Pharmaceuticals and Seelos Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Algernon Pharmaceuticals and Seelos Therapeutics
The main advantage of trading using opposite Algernon Pharmaceuticals and Seelos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algernon Pharmaceuticals position performs unexpectedly, Seelos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seelos Therapeutics will offset losses from the drop in Seelos Therapeutics' long position.| Algernon Pharmaceuticals vs. Cellectis SA | Algernon Pharmaceuticals vs. Biotron Limited | Algernon Pharmaceuticals vs. Resverlogix Corp | Algernon Pharmaceuticals vs. Covalon Technologies |
| Seelos Therapeutics vs. ATAI Life Sciences | Seelos Therapeutics vs. Mind Medicine | Seelos Therapeutics vs. GH Research PLC | Seelos Therapeutics vs. Cybin Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |